HPLC-based activity profiling for GABAA receptor modulators in Adenocarpus cincinnatus

Area of Science:

• Pharmacology
• Neuroscience
• Natural Products Chemistry

Background:

• The GABAA receptor is a primary inhibitory neurotransmitter receptor in the central nervous system.
• Modulators of GABAA receptors are crucial for treating neurological and psychiatric disorders.
• Natural products offer a rich source of novel therapeutic agents.

Purpose of the Study:

• To investigate the potential of Adenocarpus cincinnatus extracts as modulators of GABAA receptors.
• To identify and characterize active compounds responsible for the observed modulatory effects.
• To explore the novel class of pterocarpans as GABAA receptor modulators.

Main Methods:

• Two-microelectrode voltage clamp electrophysiology in Xenopus laevis oocytes expressing specific GABAA receptor subtypes (α1β2γ2s).
• HPLC-based activity profiling to isolate and identify compounds from the plant extract.
• Determination of EC50 values and maximal potentiation for active compounds.

Main Results:

• A dichloromethane extract of Adenocarpus cincinnatus significantly enhanced GABA-induced chloride currents (IGABA) by 126.5% at 100 μg/mL.
• Fifteen flavonoid and isoflavonoid derivatives, including eight new compounds, were identified.
• Isoflavone 11 and pterocarpans 2 and 8 demonstrated potent GABAA receptor modulation with EC50 values between 2.8–18.8 μM and maximal potentiation up to 640%.

Conclusions:

• Adenocarpus cincinnatus contains compounds that effectively modulate GABAA receptor activity.
• Pterocarpans represent a newly identified class of GABAA receptor modulators.
• These findings highlight the therapeutic potential of Adenocarpus cincinnatus constituents for neurological conditions.